BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9886618)

  • 1. Enzyme-linked immunosorbent assay detection of prostate-specific antigen messenger ribonucleic acid in prostate cancer.
    Hoshi S; Kobayashi S; Takahashi T; Suzuki KI; Kawamura S; Satoh M; Chiba Y; Orikasa S
    Urology; 1999 Jan; 53(1):228-35. PubMed ID: 9886618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Detection of PSA mRNA from the peripheral blood and pelvic lymph nodes in patients with prostatic cancer by means of reverse transcription-polymerase chain reaction (RT-PCR)].
    Mao H; Hoshi S; Takahashi T; Kaneda T; Wang J; Suzuki K; Orikasa S
    Nihon Hinyokika Gakkai Zasshi; 1998 Jun; 89(6):596-603. PubMed ID: 9666686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reverse transcriptase polymerase chain reaction for prostate specific antigen in the management of prostate cancer.
    Gomella LG; Raj GV; Moreno JG
    J Urol; 1997 Aug; 158(2):326-37. PubMed ID: 9224297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of combined "triple"-reverse transcription-PCR analysis for prostate-specific antigen, human kallikrein 2, and prostate-specific membrane antigen mRNA in peripheral blood and lymph nodes of prostate cancer patients.
    Kurek R; Nunez G; Tselis N; Konrad L; Martin T; Roeddiger S; Aumüller G; Zamboglou N; Lin DW; Tunn UW; Renneberg H
    Clin Cancer Res; 2004 Sep; 10(17):5808-14. PubMed ID: 15355910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Genetic diagnosis of pelvic lymph node metastasis using fine needle aspiration samples in prostate cancer].
    Hoshi S; Orikasa S; Takahashi T; Suzuki K; Kaneda T; Saitoh H; Yoshikawa K; Ono K; Hikichi Y; Ohkawa A; Funato T
    Hinyokika Kiyo; 1996 Oct; 42(10):781-5. PubMed ID: 8951475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-Time quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) for the measurement of prostate-specific antigen mRNA in the peripheral blood of patients with prostate carcinoma using the taqman detection system.
    Gelmini S; Tricarico C; Vona G; Livi L; Melina AD; Serni S; Cellai E; Magrini S; Villari D; Carini M; Serio M; Forti G; Pazzagli M; Orlando C
    Clin Chem Lab Med; 2001 May; 39(5):385-91. PubMed ID: 11434386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Genetic diagnosis of pelvic lymph node metastasis in prostate cancer using aspiration biopsy samples].
    Takahashi T; Hoshi S; Kaneda T; Mou K; Orikasa S; Ohkawa A; Funato T; Sasaki T; Kimura N
    Rinsho Byori; 1996 Dec; 44(12):1183-8. PubMed ID: 8990938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The study of PSA gene expression on urogenital cell lines.
    Takahashi T; Hoshi S; Satoh M; Kaneda T; Suzuki KI; Nakagawara KI; Orikasa S
    Int J Urol; 1999 Oct; 6(10):526-31. PubMed ID: 10533904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of prostate specific antigen mRNA in peripheral blood by reverse transcriptase polymerase chain reaction and a simple chemiluminometric hybridization assay in a high-throughput format.
    Emmanouilidou E; Ioannou PC; Christopoulos TK; Polizois K
    Anal Biochem; 2003 Feb; 313(1):97-105. PubMed ID: 12576064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transrectal ultrasound-guided biopsy causes hematogenous dissemination of prostate cells as determined by RT-PCR.
    Moreno JG; O'Hara SM; Long JP; Veltri RW; Ning X; Alexander AA; Gomella LG
    Urology; 1997 Apr; 49(4):515-20. PubMed ID: 9111619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of prostate-specific antigen- or prostate-specific membrane antigen-positive circulating cells in prostatic cancer patients: clinical implications.
    Millon R; Jacqmin D; Muller D; Guillot J; Eber M; Abecassis J
    Eur Urol; 1999 Oct; 36(4):278-85. PubMed ID: 10473985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of prostate specific antigen messenger RNA from pelvic lymph node in prostate cancer.
    Hoshi S; Orikasa S; Takahashi T; Kaneda T; Mao H; Ohkawa A; Funatob T; Kimura N
    Urol Oncol; 1997; 3(5-6):183-8. PubMed ID: 21227143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of prostate-specific antigen RNA before and after radical retropubic prostatectomy and transurethral resection of the prostate using "Light-Cycler"-based quantitative real-time polymerase chain reaction.
    Straub B; Müller M; Krause H; Schrader M; Goessl C; Heicappell R; Miller K
    Urology; 2001 Nov; 58(5):815-20. PubMed ID: 11711374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined nested reverse transcription-PCR assay for prostate-specific antigen and prostate-specific membrane antigen in detecting circulating prostatic cells.
    Zhang Y; Zippe CD; Van Lente F; Klein EA; Gupta MK
    Clin Cancer Res; 1997 Jul; 3(7):1215-20. PubMed ID: 9815802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of alpha-fetoprotein and prostate-specific antigen genes in several tissues and detection of mRNAs in normal circulating blood by reverse transcriptase-polymerase chain reaction.
    Ishikawa T; Kashiwagi H; Iwakami Y; Hirai M; Kawamura T; Aiyoshi Y; Yashiro T; Ami Y; Uchida K; Miwa M
    Jpn J Clin Oncol; 1998 Dec; 28(12):723-8. PubMed ID: 9879288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of circulating prostate cells by reverse transcriptase-polymerase chain reaction of human glandular kallikrein (hK2) and prostate-specific antigen (PSA) messages.
    Corey E; Arfman EW; Oswin MM; Melchior SW; Tindall DJ; Young CY; Ellis WJ; Vessella RL
    Urology; 1997 Aug; 50(2):184-8. PubMed ID: 9255285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-time RT-PCR for the measurement of prostate-specific antigen mRNA expression in benign hyperplasia and adenocarcinoma of prostate.
    Gelmini S; Tricarico C; Petrone L; Forti G; Amorosi A; Dedola GL; Serio M; Pazzagli M; Orlando C
    Clin Chem Lab Med; 2003 Mar; 41(3):261-5. PubMed ID: 12705330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blinded evaluation of reverse transcriptase-polymerase chain reaction prostate-specific antigen peripheral blood assay for molecular staging of prostate cancer.
    Gao CL; Maheshwari S; Dean RC; Tatum L; Mooneyhan R; Connelly RR; McLeod DG; Srivastava S; Moul JW
    Urology; 1999 Apr; 53(4):714-21. PubMed ID: 10197846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Numeric definition of the clinical performance of the nested reverse transcription-PCR for detection of hematogenous epithelial cells and correction for specific mRNA of non-target cell origin as evaluated for prostate cancer cells.
    Schamhart D; Swinnen J; Kurth KH; Westerhof A; Kusters R; Borchers H; Sternberg C
    Clin Chem; 2003 Sep; 49(9):1458-66. PubMed ID: 12928226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of micrometastatic prostate cancer cells in the lymph nodes by reverse transcriptase polymerase chain reaction is predictive of biochemical recurrence in pathological stage T2 prostate cancer.
    Okegawa T; Nutahara K; Higashihara E
    J Urol; 2000 Apr; 163(4):1183-8. PubMed ID: 10737491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.